A national survey examining obstetrician perspectives on use of 17-alpha hydroxyprogesterone caproate post-US FDA approval.
about
A national survey examining obstetrician perspectives on use of 17-alpha hydroxyprogesterone caproate post-US FDA approval.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A national survey examining ob ...... caproate post-US FDA approval.
@en
A national survey examining ob ...... caproate post-US FDA approval.
@nl
type
label
A national survey examining ob ...... caproate post-US FDA approval.
@en
A national survey examining ob ...... caproate post-US FDA approval.
@nl
prefLabel
A national survey examining ob ...... caproate post-US FDA approval.
@en
A national survey examining ob ...... caproate post-US FDA approval.
@nl
P2860
P50
P1476
A national survey examining ob ...... caproate post-US FDA approval.
@en
P2093
Daniel Saltzman
Nathan Fox
P2860
P304
P356
10.1007/S40261-013-0099-4
P577
2013-08-01T00:00:00Z